License, Clinical Trial and Sponsored Research Agreements (Details Textual) - USD ($) |
1 Months Ended | 9 Months Ended | |||
|---|---|---|---|---|---|
Aug. 02, 2018 |
Sep. 30, 2018 |
Sep. 30, 2017 |
Mar. 17, 2018 |
Jan. 03, 2018 |
|
| Payments to Acquire Intangible Assets | $ 1,075,000 | $ 2,375,000 | |||
| Revenue Recognition, Milestone Method, Revenue Recognized | $ 13,500,000 | ||||
| License [Member] | |||||
| Payments to Acquire Intangible Assets | 1,000,000 | ||||
| Annual Maintenance Fee | $ 100,000 | ||||
| City Of Hope [Member] | |||||
| Research And Development Expense, Sponsored Research Payment | $ 900,000 | ||||
| City Of Hope [Member] | Patent and Know-how Rights [Member] | |||||
| Research And Development Expense, Sponsored Research Payment | $ 75,000 | ||||
| Fred Hutchinson Cancer Research Center [Member] | |||||
| Research And Development Expense, Sponsored Research Payment | $ 600,000 | ||||
| X | ||||||||||
- Definition Amount of annual maintanence fee in consideration for exclusive license. No definition available.
|
| X | ||||||||||
- Definition The amount of research and development expense payable on achieving milestone targets. No definition available.
|
| X | ||||||||||
- Definition The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of consideration recognized during the period for the milestone or milestones. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|